Alex Ignatchenko

Alex Ignatchenko

Auto-generated profile, based on publicly available information

Alex Ignatchenko

Princess Margaret Cancer Center, Toronto, Ontario, Canada

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 March 2023 in Genetics
Verified
Journal Article
Open access
PDF file
TCThe Gene Ontology Consortium
The Gene Ontology Consortium
SASuzi A Aleksander
Suzi A Aleksander
JBJames Balhoff
James Balhoff
SCSeth Carbon
Seth Carbon
JCJ Michael Cherry
J Michael Cherry
MWMonte Westerfield
Monte Westerfield
The Gene Ontology (GO) knowledgebase (http://geneontology.org) is a comprehensive resource concerning the functions of genes and gene products (proteins and noncoding RNAs). GO annotations cover genes from organisms across the tree of life as well as viruses, though most gene function knowledge currently derives from experiments carried out in a relatively small number of model organisms. Here, we provide an updated overview of the GO knowledgebase, as well as the efforts of the broad, international consortium of scientists that develops, maintains, and updates the GO knowledgebase. The GO knowledgebase consists of three components: (1) the GO—a computational knowledge structure describing the functional characteristics of genes; (2) GO annotations—evidence-supported statements asserting that a specific gene product has a particular functional characteristic; and (3) GO Causal Activity Models (GO-CAMs)—mechanistic models of molecular “pathways” (GO biological processes) created by linking multiple GO annotations using defined relations. Each of these components is continually expanded, revised, and updated in response to newly published discoveries and receives extensive QA checks, reviews, and user feedback. For each of these components, we provide a description of the current contents, recent developments to keep the knowledgebase up to date with new discoveries, and guidance on how users can best make use of the data that we provide. We conclude with future directions for the project.

22 March 2006 in Nature
Verified
Journal Article
Closed access
PDF file
NKNevan J. Krogan
Nevan J. Krogan
GCGerard Cagney
Gerard Cagney
HYHaiyuan Yu
Haiyuan Yu
GZGouqing Zhong
Gouqing Zhong
XGXinghua Guo
Xinghua Guo
JGJack F. Greenblatt
Jack F. Greenblatt

25 March 2008 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
YSYang Shen
Yang Shen
OLOliver Lange
Oliver Lange
FDFrank Delaglio
Frank Delaglio
PRPaolo Rossi
Paolo Rossi
JAJames M. Aramini
James M. Aramini
ABAdriaan Bax
Adriaan Bax
Protein NMR chemical shifts are highly sensitive to local structure. A robust protocol is described that exploits this relation for de novo protein structure generation, using as input experimental parameters the 13 C α , 13 C β , 13 C′, 15 N, 1 H α and 1 H N NMR chemical shifts. These shifts are generally available at the early stage of the traditional NMR structure determination process, before the collection and analysis of structural restraints. The chemical shift based structure determination protocol uses an empirically optimized procedure to select protein fragments from the Protein Data Bank, in conjunction with the standard ROSETTA Monte Carlo assembly and relaxation methods. Evaluation of 16 proteins, varying in size from 56 to 129 residues, yielded full-atom models that have 0.7–1.8 Å root mean square deviations for the backbone atoms relative to the experimentally determined x-ray or NMR structures. The strategy also has been successfully applied in a blind manner to nine protein targets with molecular masses up to 15.4 kDa, whose conventional NMR structure determination was conducted in parallel by the Northeast Structural Genomics Consortium. This protocol potentially provides a new direction for high-throughput NMR structure determination.

1 April 2006 in Cell
Verified
Journal Article
Closed access
TKThomas Kislinger
Thomas Kislinger
BCBrian Cox
Brian Cox
AKAnitha Kannan
Anitha Kannan
CCClement Chung
Clement Chung
PHPingzhao Hu
Pingzhao Hu
AEAndrew Emili
Andrew Emili

10 November 2021 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
PBParit Bansal
Parit Bansal
AMAnne Morgat
Anne Morgat
KAKristian B Axelsen
Kristian B Axelsen
VMVenkatesh Muthukrishnan
Venkatesh Muthukrishnan
ECElisabeth Coudert
Elisabeth Coudert
ABAlan Bridge
Alan Bridge
Rhea (https://www.rhea-db.org) is an expert-curated knowledgebase of biochemical reactions based on the chemical ontology ChEBI (Chemical Entities of Biological Interest) (https://www.ebi.ac.uk/chebi). In this paper, we describe a number of key developments in Rhea since our last report in the database issue of Nucleic Acids Research in 2019. These include improved reaction coverage in Rhea, the adoption of Rhea as the reference vocabulary for enzyme annotation in the UniProt knowledgebase UniProtKB (https://www.uniprot.org), the development of a new Rhea website, and the designation of Rhea as an ELIXIR Core Data Resource. We hope that these and other developments will enhance the utility of Rhea as a reference resource to study and engineer enzymes and the metabolic systems in which they function.

16 June 2009 in Molecular Systems Biology
Verified
Journal Article
Open access
PDF file
BCBrian Cox
Brian Cox
MKMax Kotlyar
Max Kotlyar
AEAndreas I Evangelou
Andreas I Evangelou
VIVladimir Ignatchenko
Vladimir Ignatchenko
AIAlex Ignatchenko
Alex Ignatchenko
TKThomas Kislinger
Thomas Kislinger
Placental abnormalities are associated with two of the most common and serious complications of human pregnancy, maternal preeclampsia (PE) and fetal intrauterine growth restriction (IUGR), each disorder affecting ∼5% of all pregnancies. An important question for the use of the mouse as a model for studying human disease is the degree of functional conservation of genetic control pathways from human to mouse. The human and mouse placenta show structural similarities, but there have been no systematic attempts to assess their molecular similarities or differences. We collected protein and mRNA expression data through shot‐gun proteomics and microarray expression analysis of the highly vascular exchange region, microdissected from the human and mouse near‐term placenta. Over 7000 ortholog genes were detected with 70% co‐expressed in both species. Close to 90% agreement was found between our human proteomic results and 1649 genes assayed by immunohistochemistry for expression in the human placenta in the Human Protein Atlas. Interestingly, over 80% of genes known to cause placental phenotypes in mouse are co‐expressed in human. Several of these phenotype‐associated proteins form a tight protein–protein interaction network involving 15 known and 34 novel candidate proteins also likely important in placental structure and/or function. The entire data are available as a web‐accessible database to guide the informed development of mouse models to study human disease. ### Synopsis The modeling of human disease in mouse has had success, but there have also been many failures. A priori , it is unclear if mutation of the orthologous gene in mouse will recapitulate the human phenotype. Although, many large‐scale datasets for microarray and proteomics exist for both mouse and human, they are rarely integrated and compared. To better predict if mutation in a mouse gene will give the equivalent phenotype as the human ortholog, a detailed molecular understanding of the orthologous/homologous tissues from human and mouse are needed. By using a dataset of ortholog gene and protein expression, comparisons can be made as to the conservation of protein interaction networks and regarding the co‐expression of phenotype‐associated proteins. One organ that can be obtained from non‐pathological human samples is the placenta. This organ is also the source of the primary defect in two of the most prevalent diseases of pregnancy, intrauterine growth restriction (IUGR) and preeclampsia (PE). Although the placentas of no two mammalian species are the same, the placentas of humans and mice have strong similarities. In both species, maternal blood from the uterine arteries enters the placenta from large diameter, spiral arteries located in the maternal decidua. The maternal blood then percolates through a dense mesh of channels created and lined by fetal trophoblast cells in which an equally dense network of fetal capillaries is localized. This region is the site of feto‐maternal exchange and is called the villous tree in humans and the labyrinth in mice. In both species, the umbilical vessels connect the fetal capillaries of the placental exchange region with the fetal body circulation. IUGR and PE, which combined affect ∼5% of all pregnancies are both associated with serious morbidity and mortality, and the only known treatment is premature delivery, which places the baby at high risk of prematurity‐related complications. Although, PE and IUGR have been intensely studied for decades, the molecular pathways, etiology and pathogenesis of these diseases remain poorly understood. Our aim was to empirically determine the molecular similarity of these two vascular exchange regions based on subcellular proteomics and transcriptional profiling, to assess the compatibility of mouse placenta to model human placenta biology. Our proteomic analysis was validated by comparison to both matched mRNA samples analyzed by microarray and to 4872 proteins assayed by immunohistochemistry (IHC) on human placenta samples in the Human Protein Atlas ([www.proteinatlas.org][1]). In both cases high correlation was found between the protein to microarray (⩾95%) and protein to IHC ⩾90%. Of key interest was the degree of molecular similarity between the mouse and human vascular exchange regions of the placenta. Data for observed proteins and their corresponding microarray probe sets were paired for human and mouse placenta samples. These protein/probe pairs were then linked between the two species using orthology data form ENSEMBL. This dataset of orthologous proteins/probes was then clustered to identify genes with common expression. This could be further classified into three categories. In all cases microarray data showed expression in both species, and protein data were observed in both species (cluster I), one species (cluster II) or in neither species (cluster III) ([Figure 2A][2]). Organellar localization associated with significant enrichment for appropriate Gene Ontology annotation terms was observed for cluster I proteins ([Figure 2B][2]). Interestingly, organellar localization showed striking agreement for co‐expressed ortholog proteins in cluster I ([Figure 2A and C][2]) as predicted by Pearson correlation, which argues for functional conservation for most ortholog proteins. Overall our analysis revealed ∼70% conserved expression of one‐to‐one ortholog genes between mouse and human placental exchange regions. We made similar comparison of microarray data deposited at the GEO repository, for other matched tissues. We found similar levels of conservation for matched tissues and lower levels against all other tissues. We next compared the level of conservation of genes that when mutant in the mouse give placenta phenotypes. We found an even higher conservation of expression of these phenotypic genes between...